Calcium channel blockers and alpha-blockers in hypertension: what is the evidence?
Mendis
S
S
Department of Medicine, Faculty of Medicine, University of Peradeniya. mendiss@who.ch
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage*; D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D011379:Prognosis; D012680:Sensitivity and Specificity; D015996:Survival Rate; D016896:Treatment Outcome
D000317:Adrenergic alpha-Antagonists; D002121:Calcium Channel Blockers